CONMED Corporation (CNMD) Earnings History
Annual and quarterly earnings data from 1990 to 2025
Loading earnings history...
CNMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CNMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 52.8% | 10.3% | 3.4% |
| 2024 | 56.1% | 15.3% | 10.1% |
| 2023 | 54.3% | 9.7% | 5.2% |
| 2022 | 54.6% | 6.7% | -7.7% |
| 2021 | 56.2% | 10.9% | 6.2% |
Download Data
Export CNMD earnings history in CSV or JSON format
Free sign-in required to download data
CONMED Corporation (CNMD) Earnings Overview
As of May 8, 2026, CONMED Corporation (CNMD) reported trailing twelve-month net income of $55M, reflecting -64.6% year-over-year growth. The company earned $1.79 per diluted share over the past four quarters, with a net profit margin of 3.4%.
Looking at the long-term picture, CNMD's 5-year EPS compound annual growth rate (CAGR) stands at +36.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $132M in fiscal 2024.
CONMED Corporation maintains positive profitability with a gross margin of 52.8%, operating margin of 10.3%, and net margin of 3.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including HOLX ($544M net income, 13.8% margin), ATRC (-$5M net income, -2.1% margin), NVCR (-$173M net income, -20.8% margin), CNMD has room to improve margins relative to the peer group. Compare CNMD vs HOLX →
CNMD Earnings vs Peers
Earnings metrics vs comparable public companies
CNMD Historical Earnings Data (1990–2025)
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $47M | -64.5% | $141M | $1.51 | 3.4% | 10.3% |
| 2024 | $132M | +105.4% | $200M | $4.26 | 10.1% | 15.3% |
| 2023 | $64M | +180.0% | $121M | $2.04 | 5.2% | 9.7% |
| 2022 | -$81M | -228.8% | $70M | $-2.68 | -7.7% | 6.7% |
| 2021 | $63M | +557.2% | $110M | $1.94 | 6.2% | 10.9% |
| 2020 | $10M | -66.7% | $46M | $0.32 | 1.1% | 5.3% |
| 2019 | $29M | -29.9% | $79M | $0.97 | 3.0% | 8.3% |
| 2018 | $41M | -26.4% | $71M | $1.41 | 4.8% | 8.3% |
| 2017 | $55M | +278.4% | $47M | $1.97 | 7.0% | 5.9% |
| 2016 | $15M | -51.9% | $38M | $0.52 | 1.9% | 4.9% |
See CNMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CNMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CNMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCNMD — Frequently Asked Questions
Quick answers to the most common questions about buying CNMD stock.
Is CNMD growing earnings?
CNMD EPS fell to $1.79, with earnings declining -64.6%. This contrasts with the 5-year CAGR of +36.4%. TTM net income dropped to $55M.
What are CNMD's profit margins?
CONMED Corporation net margin is +3.4%, with operating margin at +10.3%. Below-average margins reflect competitive or cost pressures.
How consistent are CNMD's earnings?
CNMD earnings data spans 1990-2025. The declining earnings trend is -64.6% YoY. Historical data enables comparison across business cycles.